International Pharmaceutical Product Registration

Author:   Anthony C. Cartwright ,  Brian R. Matthews
Publisher:   Taylor & Francis Inc
Edition:   2nd edition
Volume:   200
ISBN:  

9781420081763


Pages:   854
Publication Date:   26 August 2009
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $441.00 Quantity:  
Add to Cart

Share |

International Pharmaceutical Product Registration


Add your own review!

Overview

Discover the latest ICH news from international experts in the pharmaceutical industry, academia, and regulatory bodies. The recent International Conference on Harmonisation (ICH) revisions of regulatory requirements for quality, nonclinical, and clinical pharmaceutical product registration are the focus of this timely update. This cutting-edge resource includes the major headings in the modular structure of the Common Technical Document (CTD), which is now the agreed format for product information submission. The format, specification, and technical requirements of the e-CTD, the electronic version of CTD, are also thoroughly discussed. The book is organized into six highly practical segments: Part I: CTD, eCTD, Module 1, and Environmental Risk Assessment Part II: CTD Summaries Part III: Quality Topics Part IV: Nonclinical Topics Part V: Clinical Topics Part VI: Other Topics (including drug-device combination products) This text is a must-have for those in the pharmaceutical industry determining regulatory requirements for the major world markets in Europe, the US, Canada, and Japan.

Full Product Details

Author:   Anthony C. Cartwright ,  Brian R. Matthews
Publisher:   Taylor & Francis Inc
Imprint:   CRC Press Inc
Edition:   2nd edition
Volume:   200
Dimensions:   Width: 17.80cm , Height: 4.60cm , Length: 25.40cm
Weight:   1.587kg
ISBN:  

9781420081763


ISBN 10:   1420081764
Pages:   854
Publication Date:   26 August 2009
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Part 1: General Topics. 1. The Common Technical Document – a global format for registration files. 2. The electronic CTD (e-CTD). 3. Module 1 of the CTD. 4. Environmental risk assessment. Part 2: CTD Summaries. 5. The Quality Overall Summary. 6. The Nonclinical Overview and Summary. 7. The Clinical Overview and Summary. Part 3: Quality Topics. 8. Drug Substance – General Information. 9. Drug Substance Manufacture. 10. Drug Substance Characterisation. 11. Control of Drug Substance. 12. Drug Substance and Drug Product – Container/Closure. 13. Drug Product – Description and Composition. 14. Drug Product – Pharmaceutical Development. 15. Drug Product – Manufacture and Process Validation. 16. Drug Product - Excipients. 17. Control of Drug Product. 18. Reference Standards or Materials. 19. Drug Substance and Drug Product Stability. 20. Viral and TSE Requirements. 21. Pharmaceutical Quality Systems. Part 4: Nonclinical. 22. Nonclinical Testing Strategy. 23. Pharmacology. 24. Pharmacokinetics and Toxicokinetics. 25. Single and repeat dose toxicity. 26. Genotoxicity. 27. Carcinogenicity. 28. Reproductive and Development Toxicity. 29. Safety pharmacology. 30. Phototoxicity. 31. Immunotoxicology. 32. Local tolerance and other toxicity studies. Part 5: Clinical Topics. 33. Bioavailability and Bioequivalence Studies. 34. Pharmacokinetics. 35. Pharmacodynamics. 36. Biostatistics: Design and Analysis of Clinical Studies. 37. Efficacy and Safety Clinical Studies. 38. Post-marketing evaluation. 39. Pharmacovigilance and risk management. 40. Studies in pregnancy and children. 41. Studies in the elderly. 42. Good Clinical Practice. 43. Prevention and detection of fraud in clinical trials. Other Topics. 44. Biological and Biotechnology Products. 45. Device Drug Combination Products. 46. Nonclinical safety assessment of nanomedicines. 47. Modelling and medical product R&D. Other. Annex 1: List of acronyms and abbreviations. Annex 2: List of key technical and regulatory information sources – published information, websites etc.

Reviews

'...it is a truly encyclopedic discussion of the CTD... Some of the material in the book is delightfully unexpected and very useful... it is a very useful book, and its content and style are most suitable for advanced study of regulatory processes or to keep by one's desk as a reference text.' - Drug Information Journal '... the book is a must-have for all experts working in the area of R&D, in particular pharmaceutical development, toxicology, pharmacology, clinical development and, of course, regulatory affairs. It will help to avoid mistakes that may lead to delays in submission of applications or deficiency letters that are received as a surprise by the applicants. In other words, to provide patients with medicines earlier, you had better have the book available next to your desk.' '...the book does provide a very good overview of all aspects of the drug registration requirements and deserves a place in every pharmaceutical library.' The British Toxicology Society Newsletter


'... the book is a must-have for all experts working in the area of R&D, in particular pharmaceutical development, toxicology, pharmacology, clinical development and, of course, regulatory affairs. It will help to avoid mistakes that may lead to delays in submission of applications or deficiency letters that are received as a surprise by the applicants. In other words, to provide patients with medicines earlier, you had better have the book available next to your desk.' '...the book does provide a very good overview of all aspects of the drug registration requirements and deserves a place in every pharmaceutical library.' The British Toxicology Society Newsletter


'... the book is a must-have for all experts working in the area of R&D, in particular pharmaceutical development, toxicology, pharmacology, clinical development and, of course, regulatory affairs. It will help to avoid mistakes that may lead to delays in submission of applications or deficiency letters that are received as a surprise by the applicants. In other words, to provide patients with medicines earlier, you had better have the book available next to your desk.' '...the book does provide a very good overview of all aspects of the drug registration requirements and deserves a place in every pharmaceutical library.' The British Toxicology Society Newsletter


Author Information

Brian R. Matthews, Anthony C. Cartwright

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

lgn

al

Shopping Cart
Your cart is empty
Shopping cart
Mailing List